All News | FDA

Advertising & Promotion

Apr 7, 2014
Ark. Supreme Court Nullifies $1.2 Billion Award Over Drug Claims, Sends Case Back to Circuit Court
Apr 7, 2014
FDA's 2015 Budget Proposal Seeks $17 Million To Review Prescription Drug Promotions
Apr 3, 2014
CVM Issues Rare Promotion-based Advisory Action Letter
Mar 24, 2014
Arkansas Supreme Court Nullifies $1.2 Billion Risperdal Award to State, Finding Misreading of Law
Mar 19, 2014
Court Orders Supplement Maker To Pay $2.19 Million Over Bogus Diabetes Claims
Mar 19, 2014
Court Orders Supplement Maker To Pay $2.19 Million Over Bogus Diabetes Claims
Mar 14, 2014
Warning Letter Blasts Device Maker for Web Claims
Mar 12, 2014
OPDP Hits Drug Maker Over Promotional Claims on Facebook
Mar 7, 2014
Aegerion Plans Corrective Advertising Effort, Warns DOJ Investigation May Prove Costly
Mar 5, 2014
FDA Updates Off-label Guidance, Adds CPGs to Allowed Texts

Good Clinical Practice

Feb 27, 2016
DOE Issues Guidance on Classified Human Subject Research
Feb 25, 2016
Goldwater Institute Calls for Congressional Changes for Compassionate Use
Feb 25, 2016
W. Va. Senate Approves ‘Right-to-Try’ Bill
Feb 25, 2016
Tuskegee and Lilly Work on Plan To Increase African American Trial Participation
Feb 24, 2016
Dr. Robert M. Califf Confirmed by Senate as New Commissioner of Food and Drugs
Feb 24, 2016
Ohio House Approves ‘Right-to-Try’ Bill
Feb 22, 2016
NIH Estimates One-third of Trials Not Posting Required Results on ClinicalTrials.gov
Feb 19, 2016
FDA Issues Revised Safety Data Collection Guidance
Feb 18, 2016
Study Finds AMCs Doing ‘Poor’ Job of Disseminating Trial Results
Feb 18, 2016
Two ‘Right-to-Try’ Bills Introduced Last Year Make Progress

FDA Regulation & Enforcement

Dec 6, 2018
FDA Gives Go-Ahead to Oleic Acid, CHD Qualified Health Claim
Dec 5, 2018
ev3 Inc. Pleads Guilty to Adulteration Charge Related to Off-Label Promotion of Neurovascular Device
Dec 5, 2018
FTC Settles False Claims Case Against Nobetes
Dec 4, 2018
Industry Group Calls for FDA Guidance on Communications About Biosimilar Products
Dec 1, 2018
Philadelphia Considers Sales Rep Registration and Gift Ban
Nov 29, 2018
Former Insys VP of Sales Pleads Guilty
Nov 28, 2018
FDA Targets Dietary Supplements Containing Tianeptine Marketed as Opioid Use Disorder Treatments
Nov 27, 2018
AMA Asks FDA for FOP Warning Labels for Added Sugars
Nov 21, 2018
CDRH Report Highlights Link Between Increased Enforcement Activity and Stepped-Up Compliance
Nov 20, 2018
In Advisory Opinion, OIG Says Providing Free Seizure Drug to Hospitals Would Raise Anti-Kickback Concerns

Copyright © Thompson FDA, a division of CBIS. All rights reserved.